Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Valacyclovir+Temovate Gel for the Episodic Treatment of Herpes Labialis: A Patient-Initiated Double-Blind, Placebo-Controlled Study, Randomized Study.

NCT00297011 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT00297011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00297011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Valacyclovir+Temovate Gel for the Episodic Treatment of Herpes Labialis: A Patient-Initiated Double-Blind, Placebo-Controlled Study, Randomized Study.
Lead sponsor
University of Utah
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2004
Completion date
January 31, 2008
Enrollment
300
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

herpes labialis